Inventor · disambiguated record
Andriy Kornilov
Also filed as: KORNILOV ANDREI M · KORNILOV ANDRIY · KORNILOV ANDRIY M
18 granted patents·3 pending applications·40 citations·filing 2008–2022
91Inventor score
Files withCAYMAN CHEMICAL CO INC11AERIE PHARMACEUTICALS INC5JOHNSON JEFFREY K2BARTA NANCY S1CHAMBOURNIER GILLES1
Top patents by PatentIndex Score
21 records- 0197US11312700B2Aryl cyclopropyl-amino-isoquinolinyl amide compoundsAERIE PHARMACEUTICALS INC·Filed 2020·Granted Apr 26, 2022·6 cites·28 claims
- 0295US10858339B2Aryl cyclopropyl-amino-isoquinolinyl amide compoundsAERIE PHARMACEUTICALS INC·Filed 2018·Granted Dec 8, 2020·9 cites·3 claims
- 0386US11427563B2Aryl cyclopropyl-amino-isoquinolinyl amide compoundsAERIE PHARMACEUTICALS INC·Filed 2019·Granted Aug 30, 2022·2 cites·32 claims
- 0486US9487478B2Difluorolactam compounds as EP4 receptor-selective agonists for use in the treatment of EP4-mediated diseases and conditionsCAYMAN CHEMICAL CO INC·Filed 2015·Granted Nov 8, 2016·4 cites·21 claims
- 0585US9180116B2Difluorolactam compounds as EP4 receptor-selective agonists for use in the treatment of EP4-mediated diseases and conditionsCAYMAN CHEMICAL CO INC·Filed 2013·Granted Nov 10, 2015·6 cites·20 claims
- 0682US9440919B2Difluorolactam compositions for EP4-mediated osteo related diseases and conditionsCAYMAN CHEMICAL CO INC·Filed 2013·Granted Sep 13, 2016·4 cites·23 claims
- 0780US9701630B2Difluorolactam compositions for EP4-mediated osteo related diseases and conditionsCAYMAN CHEMICAL CO INC·Filed 2016·Granted Jul 11, 2017·2 cites·20 claims
- 0878US12018012B2Aryl cyclopropyl-amino-isoquinolinyl amide compoundsAERIE PHARMACEUTICALS INC·Filed 2022·Granted Jun 25, 2024·0 cites·23 claims
- 0977US11884624B2Difluorolactam compounds as EP4 receptor-selective agonists for use in the treatment of EP4-mediated diseases and conditionsCAYMAN CHEMICAL CO INC·Filed 2021·Granted Jan 30, 2024·0 cites·3 claims
- 1077US8901319B2Process for the preparation of F-series prostaglandinsCHAMBOURNIER GILLES·Filed 2009·Granted Dec 2, 2014·7 cites·39 claims
- 1175US11891376B2Aryl cyclopropyl-amino-isoquinolinyl amide compoundsAERIE PHARMACEUTICALS INC·Filed 2022·Granted Feb 6, 2024·0 cites·27 claims
- 1273US11066361B2Difluorolactam compounds as EP4 receptor-selective agonists for use in the treatment of EP4-mediated diseases and conditionsCAYMAN CHEMICAL CO INC·Filed 2020·Granted Jul 20, 2021·0 cites·3 claims
- 1366US11345690B2Methods of synthesizing a difluorolactam analogCAYMAN CHEMICAL CO INC·Filed 2019·Granted May 31, 2022·0 cites·3 claims
- 1460US9914725B2Methods of synthesizing a difluorolactam analogCAYMAN CHEMICAL CO INC·Filed 2014·Granted Mar 13, 2018·0 cites·4 claims
- 1554US2018170918A1Methods of synthesizing a difluorolactam analogCAYMAN CHEMICAL CO INC·Filed 2018·Application pending·0 cites
- 1649US10729810B2Methods, systems, and compositions for promoting bone growthCAYMAN CHEMICAL CO INC·Filed 2014·Granted Aug 4, 2020·0 cites·16 claims
- 1747US9676712B2Lactam compounds as EP4 receptor-selective agonists for use in the treatment of EP4-mediated diseases and conditionsCAYMAN CHEMICAL CO INC·Filed 2014·Granted Jun 13, 2017·0 cites·24 claims
- 1843US8680327B2Methods for manufacturing tetranor-prostaglandin D, J, E, A and F metabolitesENDRES GREGORY W·Filed 2011·Granted Mar 25, 2014·0 cites·13 claims
- 1943US8063240B2Prostaglandin E1 and E2 analogs for the treatment of various medical conditionsBARTA NANCY S·Filed 2008·Granted Nov 22, 2011·0 cites·14 claims
- 2034US2012021437A1Tetranor-pgdm/pgjm specific immunogens, antibodies, tracers, assay kits and methods for making sameJOHNSON JEFFREY K·Filed 2011·Application pending·0 cites
- 2134US2011311990A1Tetranor-pgem/pgam specific immunogens, antibodies, tracers, assay kits and methods for making sameJOHNSON JEFFREY K·Filed 2011·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →